NeueHealth, Inc. (NEUE) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
NEUE currently has 8.98M outstanding shares. with limited dilution risk as only 840K additional shares (9.4%) are authorized for issuance. The company has diluted shareholders by 11.45% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Oct 02, 2025 |
8-K filing: The Company issued warrants representing the Holders' right to purchase 1,116,765 shares of Company Common Stock at an exercise price of $0.01 per share in a private placement. |
9M | 840K |
| Aug 07, 2025 |
10-Q filing | 9.0M shares outstanding |
9M | 840K |
| May 09, 2025 |
10-Q filing | 8.6M shares outstanding |
8.6M | 840K |
| Mar 21, 2025 |
10-K filing | 8.2M shares outstanding |
8.2M | 840K |
| Nov 07, 2024 |
10-Q filing | 8.3M shares outstanding |
8.3M | 840K |
| Aug 13, 2024 |
10-Q filing | 8.3M shares outstanding |
8.3M | 840K |
| Jun 24, 2024 |
8-K filing: NeueHealth, Inc. entered into warrant agreements on June 21, 2024, granting lenders the right to purchase up to 1,250,000 shares of common stock at an exercise price of $0.01 per share. |
8.1M | 840K |
| May 10, 2024 |
10-Q filing | 8.1M shares outstanding |
8.1M | 840K |
| Mar 28, 2024 |
10-K filing | 8.0M shares outstanding |
8M | 840K |
| Nov 09, 2023 |
10-Q filing | 8.0M shares outstanding |
8M | 840K |
| Aug 09, 2023 |
10-Q filing | 8.0M shares outstanding |
8M | 840K |
| May 19, 2023 |
Stock Split
8-K filing: Stock split 1-for-80 | Outstanding: 631,534,000 → 7,894,175 |
7.9M | 840K |
| May 10, 2023 |
10-Q filing | 631.5M shares outstanding |
630M | 67M |
| Mar 16, 2023 |
10-K filing | 629.5M shares outstanding |
630M | 67M |
| Nov 14, 2022 |
10-Q filing | 629.7M shares outstanding |
630M | 67M |
| Oct 18, 2022 |
8-K filing: Bright Health Group, Inc. completed the issuance and sale of 175,000 shares of Series B Convertible Perpetual Preferred Stock for $175.0 million on October 17, 2022. ($175.0M proceeds) |
630M | 67M |
| Oct 11, 2022 |
8-K filing: Bright Health Group, Inc. entered into an Investment Agreement for the issuance and sale of 175,000 shares of Series B Convertible Perpetual Preferred Stock for $175.0 million. ($175.0M proceeds) |
630M | 67M |
| Aug 15, 2022 |
10-Q filing | 629.2M shares outstanding |
630M | 67M |
| May 12, 2022 |
10-Q filing | 628.8M shares outstanding |
630M | 67M |
| Mar 18, 2022 |
10-K filing | 628.8M shares outstanding |
630M | 67M |
| Jan 03, 2022 |
8-K filing: Bright Health Group, Inc. completed the issuance and sale of 750,000 shares of Series A Convertible Perpetual Preferred Stock to certain subsidiaries of Cigna Corporation and certain affiliates of New Enterprise Associates for an aggregate purchase price of $750.0 million, or $1,000 per share. ($750.0M proceeds) |
630M | 67M |
| Dec 07, 2021 |
8-K filing: Bright Health Group, Inc. entered into an Investment Agreement with a subsidiary of Cigna Corporation and an affiliate of New Enterprise Associates for the issuance and sale of 750,000 shares of Series A Convertible Perpetual Preferred Stock at $1,000 per share, for an aggregate purchase price of $750.0 million. ($750.0M proceeds) |
630M | 67M |
| Nov 15, 2021 |
10-Q filing | 628.3M shares outstanding |
630M | 67M |
| Aug 11, 2021 |
10-Q filing | 630.2M shares outstanding |
630M | 67M |
| Jun 15, 2021 |
S-1/A filing: Bright Health Group, Inc. is offering 60,000,000 shares of common stock in its initial public offering, with an estimated price between $20.00 and $23.00 per share, and has granted underwriters an option to purchase up to 7,200,000 additional shares. |
N/A | 67M |
| Jun 04, 2021 |
S-1/A filing: This is the initial public offering of Bright Health Group, Inc. We are selling shares of our common stock. We estimate the initial public offering price of our common stock to be between $ and $ per share. |
N/A | 0 |